Your browser is no longer supported. Please, upgrade your browser.
OPGN OPGEN INC daily Stock Chart
OPGN [NASD]
OPGEN INC
Index- P/E- EPS (ttm)-1.13 Insider Own0.20% Shs Outstand27.66M Perf Week0.93%
Market Cap30.15M Forward P/E- EPS next Y-0.32 Insider Trans0.00% Shs Float21.81M Perf Month-4.39%
Income-19.50M PEG- EPS next Q-0.15 Inst Own33.40% Short Float7.09% Perf Quarter-14.84%
Sales4.00M P/S7.54 EPS this Y21.30% Inst Trans- Short Ratio4.46 Perf Half Y-38.07%
Book/sh0.14 P/B7.79 EPS next Y31.90% ROA-185.30% Target Price2.00 Perf Year-22.14%
Cash/sh0.15 P/C7.35 EPS next 5Y- ROE-442.70% 52W Range0.87 - 4.65 Perf YTD-5.22%
Dividend- P/FCF- EPS past 5Y- ROI-422.40% 52W High-77.85% Beta-
Dividend %- Quick Ratio0.90 Sales past 5Y- Gross Margin47.80% 52W Low18.39% ATR0.07
Employees59 Current Ratio1.10 Sales Q/Q-23.10% Oper. Margin- RSI (14)42.56 Volatility6.01% 6.05%
OptionableNo Debt/Eq0.41 EPS Q/Q43.90% Profit Margin- Rel Volume1.11 Prev Close1.09
ShortableYes LT Debt/Eq0.03 EarningsApr 26 AMC Payout- Avg Volume346.61K Price1.03
Recom2.00 SMA20-7.10% SMA50-3.95% SMA200-25.42% Volume383,340 Change-5.50%
Jun-29-16Initiated Rodman & Renshaw Buy $2.50
Apr-27-17 08:00AM  OpGen Appoints Tina S. Nova, Ph.D. to Board of Directors GlobeNewswire -5.50%
Apr-26-17 04:00PM  OpGen Announces 2017 First Quarter Financial Results GlobeNewswire
Apr-25-17 03:44PM  ETFs with exposure to OpGen, Inc. : April 25, 2017 Capital Cube +6.67%
08:00AM  OpGen Highlights Capabilities of its Acuitas® Technologies to Rapidly Predict Antibiotic Susceptibility Using Drug Resistance Gene Profiles at ECCMID GlobeNewswire
Apr-19-17 04:15PM  OpGen Announces Date of First Quarter 2017 Financial Results Conference Call GlobeNewswire
Apr-13-17 02:39PM  UPDATE -- OpGen to Present Antibiotic Resistance Prediction Data at 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) GlobeNewswire
Apr-12-17 04:30PM  OpGen to Present Antibiotic Resistance Prediction Data at 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) GlobeNewswire
Apr-05-17 05:14PM  ETFs with exposure to OpGen, Inc. : April 5, 2017 Capital Cube
Mar-30-17 01:04PM  OPGEN INC Financials
Mar-28-17 12:46PM  OpGen, Inc. :OPGN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 28, 2017 Capital Cube
10:33AM  OpGen, Inc. :OPGN-US: Earnings Analysis: 2016 By the Numbers : March 28, 2017
Mar-24-17 04:04PM  OPGEN INC Files SEC form 10-K, Annual Report
10:29AM  Edited Transcript of OPGN earnings conference call or presentation 23-Mar-17 8:30pm GMT Thomson Reuters StreetEvents
Mar-23-17 04:32PM  OPGEN INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:30PM  OpGen Inc Earnings Call scheduled for 4:30 pm ET today
04:01PM  OpGen Announces 2016 Fourth Quarter and Year End Financial Results GlobeNewswire
07:07AM  Q4 2016 OpGen Inc Earnings Release - After Market Close
Mar-01-17 08:00AM  OpGen to Present at the Cowen and Company 37th Annual Health Care Conference GlobeNewswire
Feb-15-17 11:29AM  Set Your Sights on This Infection-Fighting Biotech Company GuruFocus.com -5.31%
Feb-14-17 12:00PM  OpGen Presents Rapid Acuitas Genetic Test Data at Advances in Genome Biology and Technology Meeting GlobeNewswire
Jan-26-17 05:38PM  OpGen Reports Preliminary Fourth Quarter and Full Year 2016 Financial Results GlobeNewswire
04:54PM  OPGEN INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Jan-17-17 08:00AM  OpGen Inc. Third Quarter 2016 Review and Fourth Quarter Earnings Outlook Accesswire -5.15%
Dec-19-16 03:30PM  OpGen Supports Passage of Landmark 21st Century Cures Act to Expedite Development of Solutions for Bacterial Infections GlobeNewswire -7.02%
Dec-16-16 04:23PM  OPGEN INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits +14.00%
09:26AM  OpGen Provides ATM Program Update GlobeNewswire
Nov-17-16 12:47PM  Heres What The OpGen Inc (OPGN) Merck & Co., Inc. (MRK) Agreement Really Means, And Why Its So Important at Insider Monkey
Nov-16-16 10:01AM  OPGEN INC Files SEC form 8-K, Regulation FD Disclosure
Nov-14-16 05:25PM  OpGen teams with Merck to fight superbugs at bizjournals.com
07:00AM  OpGen Collaborates With Merck to Develop Novel Rapid Diagnostics and Informatics Tools to Combat Antibiotic Resistance GlobeNewswire
06:13AM  OPGEN INC Files SEC form 10-Q, Quarterly Report
Oct-27-16 04:25PM  Large Integrated Health Outcomes Study Reveals Shifting Epidemiology In Drug Resistant Organisms GlobeNewswire -10.85%
Oct-26-16 08:00AM  OpGens Infectious Disease Portfolio Highlighted at IDWeek 2016 GlobeNewswire -5.83%
Oct-25-16 10:50AM  OpGen, Inc. :OPGN-US: Earnings Analysis: Q3, 2016 By the Numbers : October 25, 2016 -22.16%
10:12AM  Edited Transcript of OPGN earnings conference call or presentation 24-Oct-16 8:30pm GMT
Oct-24-16 04:33PM  OPGEN INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:30PM  OpGen Inc Earnings Call scheduled for 4:30 pm ET today
04:01PM  OpGen Reports 2016 Third Quarter Financial Results and Provides Business Update GlobeNewswire
07:07AM  Q3 2016 OpGen Inc Earnings Release - After Market Close
Oct-20-16 09:02AM  OPGEN INC Files SEC form 8-K, Entry into a Material Definitive Agreement
Oct-19-16 05:10PM  OpGen Announces Date of Third Quarter 2016 Financial Results Conference Call GlobeNewswire
Sep-14-16 05:26PM  OPGEN INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Sep-08-16 07:30AM  OpGen, Inc. to Host Anti-Infectives Roundtable at the World Anti-Microbial Resistance Congress GlobeNewswire
Sep-07-16 07:30AM  OpGen to Present at the Rodman & Renshaw 18th Annual Global Investment Conference GlobeNewswire
Sep-02-16 04:38PM  OPGEN INC Files SEC form 8-K, Change in Directors or Principal Officers
Aug-11-16 04:07PM  OPGEN INC Files SEC form 10-Q, Quarterly Report -13.06%
11:23AM  OpGen, Inc. :OPGN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016
Aug-10-16 03:22PM  Edited Transcript of OPGN earnings conference call or presentation 9-Aug-16 8:30pm GMT +6.73%
Aug-09-16 04:30PM  OpGen Inc Earnings Call scheduled for 4:30 pm ET today
04:17PM  OPGEN INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:02PM  OpGen Reports 2016 Second Quarter Financial Results and Provides Business Update GlobeNewswire
07:07AM  Q2 2016 OpGen Inc Earnings Release - Before Market Open
Aug-08-16 11:26AM  OpGen Announces Completion of the Intermountain Healthcare Retrospective MDRO Health Outcome Study GlobeNewswire
Aug-02-16 08:30AM  OpGen, Inc. Announces Timing for Second Quarter Financial Results and Conference Call GlobeNewswire
Jul-22-16 07:00AM  Why SFHI Could Follow Nintendo, OpGen or Liquidmetal In Unexpected Surge
Jul-20-16 04:12PM  Lack of Market Exposure Bothers Bulls +135.67%
Jul-19-16 01:15PM  Merck & Co., Inc. (MRK) and OpGen Inc (OPGN) Are Quietly Changing The Infectious Disease Landscape at Insider Monkey +12.23%
Jun-29-16 07:07AM  Coverage initiated on OpGen by Rodman & Renshaw
Jun-24-16 04:10PM  OPGEN INC Files SEC form 8-K, Change in Directors or Principal Officers
Jun-20-16 12:30PM  OpGen Highlights Strong Performance of Acuitas® Resistome Test at ASM Microbe 2016 GlobeNewswire
Jun-06-16 05:04PM  OPGEN INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements a
12:11PM  OpGen, Inc. :OPGN-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016
Jun-02-16 08:00AM  OpGen to Present at the 6th Annual LD Micro Invitational Conference Accesswire -5.39%
Jun-01-16 12:30PM  Merck & Co. venture arm backs superbug fighter OpGen in $10.3 million funding round at bizjournals.com -6.18%
May-26-16 09:35AM  Capital Infusions Are More Evidence of a Biotech Turnaround at 24/7 Wall St. -6.58%
May-20-16 04:14PM  OPGEN INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws; C
10:14AM  OpGen Announces Closing of $10 Million Private Placement GlobeNewswire
May-18-16 06:52AM  Edited Transcript of OPGN earnings conference call or presentation 12-May-16 8:30pm GMT
May-17-16 05:28PM  OPGEN INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
09:00AM  OpGen Supports New White House National Microbiome Initiative GlobeNewswire
May-16-16 09:04AM  OPGEN INC Files SEC form 10-Q, Quarterly Report -7.89%
May-13-16 06:03AM  OPGEN INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits +10.68%
May-12-16 04:30PM  OpGen Inc Earnings Call scheduled for 4:30 pm ET today
04:01PM  OpGen Reports 2016 First Quarter Financial Results and Business Update GlobeNewswire
09:14AM  OPGEN INC Files SEC form 8-K, Other Events EDGAR Online
09:01AM  OpGen Announces Pricing of $10 Million Private Placement GlobeNewswire
May-10-16 02:03PM  OpGen, Inc. Announces Timing for First Quarter Financial Results and Conference Call GlobeNewswire
May-04-16 07:30AM  OpGen and District of Columbia Hospital Association Complete First Citywide Quantification of Multidrug-Resistant Organism (MDRO) Prevalence in Washington, D.C.-based Healthcare Facilities GlobeNewswire
May-03-16 04:43PM  OPGEN INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
09:05AM  3 Underfollowed Infectious Disease Stocks That Deserve More Attention at 24/7 Wall St.
May-02-16 04:43PM  OPGEN INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
12:22PM  OpGen Appoints Harry J. D'Andrea to Board of Directors GlobeNewswire
Apr-11-16 07:30AM  New Study Data Show OpGens QuickFISH® Blood Culture Pathogen ID Tests to be Rapid and Cost-Effective, with Utility to Inform Antimicrobial Stewardship Decisions GlobeNewswire +9.22%
Mar-30-16 10:00AM  OpGen Inc Earnings Call scheduled for 10:00 am ET today
07:50AM  OpGen Announces 2015 Fourth Quarter and Full Year Financial Results at noodls
07:46AM  OPGEN INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:30AM  OpGen Announces 2015 Fourth Quarter and Full Year Financial Results GlobeNewswire
07:07AM  Q4 2015 OpGen Inc Earnings Release - Time Not Supplied
Mar-21-16 07:47AM  OpGen Announces New Members to its Clinical Advisory Board at noodls +14.71%
07:30AM  OpGen Announces New Members to its Clinical Advisory Board GlobeNewswire
Mar-16-16 11:09AM  OpGen, Inc. Announces Timing for 2015 Fourth Quarter and Year End Financial Results and Conference Call GlobeNewswire -8.81%
Feb-03-16 08:00AM  OpGen to Present at Source Capital Groups 2016 Disruptive Growth & Healthcare Conference GlobeNewswire
Jan-13-16 04:00PM  OpGen, Inc., to Present at Noble Financial Capital Markets 12th Annual Investor Conference GlobeNewswire
Jan-12-16 09:21AM  OPGEN INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -5.91%
Dec-17-15 08:30AM  OpGen's QuickFISH Rapid Pathogen ID Test Demonstrates Clinical Utility and Cost Effectiveness in Community Hospitals Antimicrobial Stewardship Program GlobeNewswire
Dec-03-15 11:27AM  OpGen, Inc. Earnings Q3, 2015
OpGen, Inc. engages in developing and deploying precision medicine tools to combat infectious disease in global healthcare settings. It helps physicians enhance patient outcomes by providing information about life-threatening infections and decreasing the spread of infections caused by multidrug-resistant microorganisms. The company offers a portfolio of in vitro diagnostic products and clinical laboratory services that employ molecular diagnostics and bioinformatics. Its QuickFISH products are a suite of FDA-cleared and CE-marked diagnostics used to detect pathogens in positive blood cultures. The company provides Acuitas MDRO gene test to identify the presence of antibiotic resistant genes for high-risk patients quickly and with high sensitivity and specificity; and Acuitas Lighthouse MDRO management system, which offers epidemiological typing, tracking, and trending to inform infection control, surveillance, and antibiotic stewardship decision makers. In addition, it offers Acuitas whole genome sequence analysis for transmission investigations and epidemiology research. OpGen, Inc. has a strategic collaboration with Hitachi High-Technologies Corporation to commercialize its genome mapping technology for mapping, assembly, and analysis of human DNA. The company was incorporated in 2001 and is headquartered in Gaithersburg, Maryland.